Objective Venous thromboembolism （VTE） is a major complication of cancer and one of the leading causes of death in patients with cancer. We therefore assessed the incidence and therapeutic options of VTE in Chinese lung cancer patients. Methods We retrospectively evaluated the charts of 260 patients with lung cancer at our ward between September 2007 and October 2008 and found 15 patients with VTE. We analyzed the clinical manifestations, diagnostic methods, treatment options, and outcomes of these patients. Results Of 15 patients, the VTE of 12 patients were contributed by central venous catheters. One patient with PE was diagnosed by CT scan, and others with venous thrombosis were confirmed by ultrasound. The low-molecular-weight heparins （LMWHs） were administered to these patients, and satisfactory results were obtained. Conclusion VTE should be carefully detected in patients with lung cancer include early detection and treatment. LMWHs have demonstrated optimistic efficacy and safety profiles.
Lung cancer, Venous thromboembolism low- molecular- weight heparin